Germany Microneedling Market

ID: MRFR/HC/48354-HCR
200 Pages
Nidhi Mandole
Last Updated: April 06, 2026
Germany Microneedling Market Research Report: Size, Share, Trend Analysis By Procedure (RF Microneedling, Traditional Microneedling, PRP Microneedling), By Product (Derma-Stamp, Dermapen, Dermarollers, RF Microneedling Devices, Others), By Needle Material (Silicon, Metal, Glass, Others), By Applications (Skin Rejuvenation, Acne Scars, Traumatic & Surgical Scars, Others) and By End-User (Hospitals, Dermatology Clinics, Homecare Settings, Others) - Growth Outlook & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Procedure (USD Million)
      1. 4.1.1 RF Microneedling
      2. 4.1.2 Traditional Microneedling
      3. 4.1.3 PRP Microneedling
    2. 4.2 Healthcare, BY Product (USD Million)
      1. 4.2.1 Derma-Stamp
      2. 4.2.2 Dermapen
      3. 4.2.3 Dermarollers
      4. 4.2.4 RF Microneedling Devices
      5. 4.2.5 Others
    3. 4.3 Healthcare, BY Needle Material (USD Million)
      1. 4.3.1 Silicon
      2. 4.3.2 Metal
      3. 4.3.3 Glass
      4. 4.3.4 Others
    4. 4.4 Healthcare, BY Application (USD Million)
      1. 4.4.1 Skin Rejuvenation
      2. 4.4.2 Acne Scars
      3. 4.4.3 Traumatic & Surgical Scars
      4. 4.4.4 Others
    5. 4.5 Healthcare, BY End-User (USD Million)
      1. 4.5.1 Hospitals
      2. 4.5.2 Dermatology Clinics
      3. 4.5.3 Homecare Settings
      4. 4.5.4 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Revance Therapeutics (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Hyaluronic Acid (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Bellus Medical (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Dermaroller (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Medytox (KR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 SkinPen (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Aesthetics Biomedical (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Eclipse MedCorp (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 GERMANY MARKET ANALYSIS BY PROCEDURE
    3. 6.3 GERMANY MARKET ANALYSIS BY PRODUCT
    4. 6.4 GERMANY MARKET ANALYSIS BY NEEDLE MATERIAL
    5. 6.5 GERMANY MARKET ANALYSIS BY APPLICATION
    6. 6.6 GERMANY MARKET ANALYSIS BY END-USER
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY PROCEDURE, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY PROCEDURE, 2024 TO 2035 (USD Million)
    15. 6.15 HEALTHCARE, BY PRODUCT, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Million)
    17. 6.17 HEALTHCARE, BY NEEDLE MATERIAL, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY NEEDLE MATERIAL, 2024 TO 2035 (USD Million)
    19. 6.19 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    21. 6.21 HEALTHCARE, BY END-USER, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PROCEDURE, 2025-2035 (USD Million)
      2. 7.2.2 BY PRODUCT, 2025-2035 (USD Million)
      3. 7.2.3 BY NEEDLE MATERIAL, 2025-2035 (USD Million)
      4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
      5. 7.2.5 BY END-USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Germany Germany Microneedling Market Segmentation

Germany Microneedling Market By Procedure (USD Million, 2025-2035)

  • RF Microneedling
  • Traditional Microneedling
  • PRP Microneedling

Germany Microneedling Market By Product (USD Million, 2025-2035)

  • Derma-Stamp
  • Dermapen
  • Dermarollers
  • RF Microneedling Devices
  • Others

Germany Microneedling Market By Needle Material (USD Million, 2025-2035)

  • Silicon
  • Metal
  • Glass
  • Others

Germany Microneedling Market By Application (USD Million, 2025-2035)

  • Skin Rejuvenation
  • Acne Scars
  • Traumatic & Surgical Scars
  • Others

Germany Microneedling Market By End-User (USD Million, 2025-2035)

  • Hospitals
  • Dermatology Clinics
  • Homecare Settings
  • Others